alphaveANTHEM₹935.35

Anthem Biosciences Ltd.

₹ CrorePeersSYNGENE DIVISLAB GLAXO AJANTPHARM IPCALAB ABBOTINDIA MEDANTA GLENMARKMcap ₹52,540 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	780.3	780.3
+ Capital Work-in-Progress	264.3	264.3
+ Investment Property	2.5	2.5
+ Other Intangibles	0.4	0.4
+ Non-current Investments	341.9	341.9
+ Long-term Loans	7.3	7.3
+ Trade Receivables — Non-current	3.1	3.1
+ Other Non-current Financial Assets	166.3	166.3
Non-current Financial Assets	518.5	518.5
+ Deferred Tax Assets	27.3	27.3
+ Other Non-current Assets	32.7	32.7
Total Non-current Assets	1,626.1	1,626.1
Current Assets
+ Inventories	124.5	124.5
+ Current Investments	665.6	665.6
+ Trade Receivables	590.6	590.6
+ Cash & Cash Equivalents	272.9	272.9
+ Other Bank Balances	2.0	2.0
+ Other Current Financial Assets	0.3	0.3
Current Financial Assets	1,531.4	1,531.4
+ Other Current Assets	147.3	147.3
Total Current Assets	1,803.1	1,803.1
Total Assets	3,429.3	3,429.3
Equity
+ Equity Share Capital	112.3	112.3
+ Other Equity / Reserves	2,930.2	2,930.2
Equity — Owners of Parent	3,042.5	3,042.5
Total Equity	3,042.5	3,042.5
Liabilities
+ Borrowings — Non-current	27.7	27.7
+ Other Non-current Financial Liab	16.3	16.3
Non-current Financial Liabilities	44.0	44.0
+ Provisions — Non-current	16.4	16.4
+ Other Non-current Liabilities	0.7	0.7
Non-current Liabilities	61.1	61.1
+ Borrowings — Current	23.3	23.3
+ Trade Payables	75.2	75.2
+ Other Current Financial Liab	5.9	5.9
Current Financial Liabilities	104.5	104.5
+ Provisions — Current	21.0	21.0
+ Current Tax Liabilities	37.3	37.3
+ Other Current Liabilities	163.0	163.0
Current Liabilities	325.7	325.7
Total Liabilities	386.8	386.8
Total Equity & Liabilities	3,429.3	3,429.3
Trade Payables — MSME split
+ Dues to Micro & Small — Current	8.9	8.9
+ Dues to Other Creditors — Current	66.3	66.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.